Introduction: The prevalence of CKD patients in advanced stages with dialysis requirement continues to grow. A goal for the medical team, the patient and their caregivers is to provide a treatment that offers an impact on the prognosis and quality of life (QOL).
Methods: In 100 patients with CKD on hemodialysis, randomized assigned, the quality of life by SF-36 was assessed, it was evaluated the functional capacity using the Karnofsky, ability to perform basic tasks of daily life through the index Barthel, presence of depression using the Beck test, family functioning through family APGAR, cognitive state through Minimental and presence of comorbidities using the Charlson index correlated with the sum of physical components (PCS) and mental components (MCS) of the SF-36 in patients in two renal units in Medellín and Bogotá, Colombia.
Results: A decrease in QOL in the physical components (PCS) Mental components (MCS) regarding the general population. A significant correlation between low PCS and diabetes mellitus (-16 p=0.008 95% CI 2.49) was found. Low MCS showed relation with PTH (p=0.046 95% CI 0.000-0.014), Karnofsky index (p=0.034 95% CI 0.244 to 5.984) and Beck depression test (p=0.000 95% CI -13.606 to 6.253).
Conclusions: The QOL of hemodialysis patients is affected with more impact on PCS, there is significant relationship between MCS with functional status and depression. To improve QOL in hemodialysis patients, non traditionally-measured variables should be measured and monitored and the therapeutic focus should be optimized addressed to physical rehabilitation, nutritional, functional and psychological state.
2. Gómez RA. Renal disease in Colombia. Ren Fail. 2006;28(8):643-7.
3. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all- ause mortality: a pooled analysis of community-based studies. J Am SocNephrol 2004;15:1307-1315.
4. Kalantar-Zadeh K, Kopple JD, Block G et al. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am SocNephrol 2001;12:2797-2806.
5. Lopes AA, Bragg-Gresham JL, Satayathum S et al. Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2003;41:605-615.
6. Lowrie EG, Curtin RB, LePain N et al. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003;41:1286-1292.
7. Unruh M, Benz R, Greene T et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int 2004;66:355-366.
8. Kimmel PL, Emont SL, Newmann JM et al. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis 2003;42:713-721.
9. Kusek JW, Greene P, Wang SR et al. Cross-sectional study of healthrelated quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension Trial. Am J Kidney Dis 2002;39:513-524.
10. Perlman RL, Finkelstein FO, Liu L et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis 2005;45:658-666.
11. Tsai YC, Hung CC, Hwang SJ, et al. Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant. 2010;25(5):1621-6.
12. Davison SN, Jhangri GS. The Relationship Between Spirituality, Psychosocial Adjustment to Illness, and Health- elated Quality of Life in Patients With Advanced Chronic idney Disease. J Pain Symptom Manage. 2012 Aug 20.
13. Davison SN, Jhangri GS. Existential and religious dimensions of spirituality and their relationship with health-related quality of life in chronic kidney disease. Clin JAm SocNephrol. 2010 Nov;5(11):1969-76.
14. Farag YM, Keithi-Reddy SR, Mittal BV, et al. Anemia, inflammation and health-related quality of life in chronic kidney disease patients. ClinNephrol. 2011 Jun;75(6):524-33.
15. Clement FM, Klarenbach S, Tonelli M, et al. The impact of selecting a high hemoglobin target level on health- elated quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med. 2009 Jun 22;169(12):1104-12.
16. Finkelstein FO, Story K, Firanek C, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am SocNephrol. 2009 Jan;4(1):33-8.
17. Covic A, Seica A, Gusbeth-Tatomir P, et al. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point? J Nephrol. 2008 Jul-Aug;21(4):478-84.
18. Johansen KL, Chertow GM. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. J Ren Nutr. 2007 Sep;17(5):305-13.
19. Mucsi I, Kovacs AZ, Molnar MZ, et al. Co-morbidity and quality of life in chronic kidney disease patients. J Nephrol. 2008 Mar-Apr;21Suppl 13:S84-91.
20. Soni RK, Porter AC, Lash JP, et al. Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis. 2010 Jul;17(4):17-26.
21. Porter A, Fischer MJ, Brooks D, et al. Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl Res. 2012 Jan;159(1):4-11.
22. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36- tem Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health construct. Med Care. 1993 Mar;31(3):247-63.
23. McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36- tem Short Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994 Jan;32(1):40-66.
24. Vilagut G, Valderas JM, Ferrer M, et al. [Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components]. Med Clin (Barc). 2008 May 4;130(19):726-35.
25. Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. MedClin (Barc). 1995 May 27;104(20):771-6.
26. Alonso J, Regidor E, Barrio G, et al. [Population reference values of the Spanish version of the Health Questionnaire SF-36]. MedClin(Barc). 1998 Oct 10;111(11):410-6.
27. Ayuso-Mateos JL, Lasa L, Vázquez-Barquero JL. [Internal and external validity of the Spanish version of SF- 6]. Med Clin (Barc). 1999 Jun 12;113(1):37.
28. Karnorfsky DA, Abelman WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1948;1:634-6456.
29. Mahoney F. Barthel D. “Functional evaluation: the Barthel Index”. Md Med J 1965;14:61-65.
30. Craven, J.L., Rodin, G.M., Littlefield, C. “The Beck Depression Inventory as a screening device for major depression in renal dialysis patients”. Int J Psychiatry Med 1988;18(4):365-374.
31. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis, 1987;40(5):373-383.
32. Folstein, M., Folstein, S.E., McHugh, P.R. “Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of PsychiatricResearch, 1975;12(3);189-198.
33. Smilkstein G. The family APGAR: a proposal for a family function test and its use by physicians. J FamPract 1978;6:1231-9.
34. Bellon JA, Delgado A, Luna del Castillo JD, Lardelli P. Validez y fiabilidad del cuestionario de función familiar Apgar- familiar. Aten Primaria 1996;18(6):289-96.
35. Mandoorah QM, Shaheen FA, Mandoorah SM, et al. Impact of demographic and comorbid conditions on quality of life of hemodialysis patients: a cross-sectional study. Saudi J Kidney Dis Transpl. 2014 Mar;25(2):432-7.
36. Van Diepen M, Schroijen MA, Dekkers OM, et al. Predicting mortality in patients with diabetes starting dialysis. PLoS One. 2014 Mar;4;9(3):e89744.
37. Arogundade FA1, Zayed B, Daba M, Barsoum RS. Correlation between Karnofsky Performance Status Scale and Short-Form Health Survey in patients on maintenance hemodialysis. J Natl Med Assoc. 2004 Dec;96(12):1661-7.
38. Grincenkov FR1, Fernandes N, Chaoubah A. Factors associated with the quality of life of incident patients on PD in Brazil (BRAZPD).J Bras Nefrol. 2011 Mar;33(1):38-44.
39. Andrade CP, Cruz MC, Urrutia M, et al. Evaluation of depressive symptoms in patients with chronic renal failure. J Nephrol. 2010 Mar-Apr; 23(2):168-74.
40. Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004 Feb 1;116(3):179-85.